Collin Stultz named co-director and MIT lead of the Harvard-MIT Program in Health Sciences and Technology
MIT professor will leverage his research into machine learning and computer science, as well as his role as a practicing cardiologist, toward educating clinician-scientists and engineers.
Rapid and accurate analytical test method enhances the production of high-quality cell therapy products.
Researchers create a mathematical framework to examine the genome and detect signatures of natural selection, deciphering the evolutionary past and future of non-coding DNA.
Novel lysin Abp013 has shown promising antimicrobial ability against Acinetobacter baumannii and Klebsiella pneumoniae.
In the intensity of basic training, a smartwatch-based system warns recruits when they are at risk of heat injury.
HASTS PhD student Rijul Kochhar tracks changing medical and microbial realities, and examines what they portend for society.
MIT Future Founders Initiative announces prize competition to promote female entrepreneurs in biotech
Nine MIT researchers selected as finalists for 2021 prize supported by Northpond Ventures; grand prize winner to receive $250K toward commercializing her human health-related invention.
In the Hoyt C. Hottel Lecture, Arnold tells the story of her pathbreaking research to engineer better enzymes for critical applications.
Udayan Umapathi SM ’17 and Will Langford SM ’14, PhD ’19 are co-founders of a Media Lab spinoff building a full-stack platform to enable automation for genomics and genetic engineering.
Public-private partnership aims to advance development and production of medical treatments.